Disclaimer: Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact Siemens Healthineers directly for availability.
The Atellica® NEPH 630 System is a mid-volume dedicated nephelometric analyzer that simplifies lab operations in specialty protein testing. The system offers the broadest menu of protein tests for assessment on urine, CSF, plasma, and serum, enabling enhanced quantification of certain health conditions. With innovative assays including FLC, CDT, and BTP, the system supports the assessment and monitoring of cardiovascular risk, kidney diseases, neurological disorders, nutritional status, and other diseases.
- Expand your testing capabilities with the broadest menu of protein tests on multiple sample types
- Minimize hands-on time so laboratory staff can focus on high-value responsibilities
- Streamline your lab workflows with highly intelligent software and IT connectivity
- Deliver accurate and secure results with antigen excess security
- Save time and reduce waste with continuous access and smart technology
- Empower clinicians to improve patient outcomes
Features & Benefits
Expand your testing capabilities with the broadest menu of protein tests on multiple sample types
- The industry’s largest nephelometric menu of plasma protein assays with more than 70 assay protocols available
- Innovative assays including free light chains (FLC), carbohydrate-deficient transferrin (CDT), and beta-trace protein (BTP)
- Supports a variety of disease states including cardiovascular risk assessment, kidney diseases, neurological disorders, nutritional assessment, iron and anemia assessment, and other diseases
Minimize hands-on time so laboratory staff can focus on high-value responsibilities
- Flexible use of different sample types in random-access mode allows convenient operation
- Onboard reagent and control storage provides 24/7 operation, long onboard stability, and minimized operator intervention
- High sample-loading capacity allows load-and-go processing
- Positive bar-code ID of primary sample tubes minimizes manual steps and avoids sample mismatch
- Automatic dilutions and repeat measurement of out-of-range high or low samples are performed without user intervention
Streamline your lab workflows with highly intelligent software and IT connectivity
- Smart Remote Services identifies and diagnoses potential hardware issues, enabling rapid technical intervention and quicker resolution
- Integration with Atellica® Process Manager simplifies lab management via aggregated system data, alerts, and the ability to remotely control Atellica NEPH 630 System and all other connected instruments―all from one screen
- Atellica Data Manager standardizes testing protocols and result management
Deliver accurate and secure results
- Proven nephelometric technology offers high precision and reproducibility
- Sophisticated antigen-excess pre-reaction protocols provide more accurate results and fewer repeats
- Wide initial measuring range reduces the need for retesting
- System detects specimen and reagent levels prior to processing to ensure accuracy of results
- Graphical display of kinetic curves allows additional insight and advanced troubleshooting
- State-of-the-art software provides a high level of cyber security
Save time and reduce waste with continuous access and smart technology
- Flexible dilutions and automatic retesting can often be performed without re-accessing the primary sample
- Fast average throughput of approximately 65 tests/hour depending on the assay mix. Nominal:100 tests/hour
- Sophisticated sample dilutions enables you to add tests or retest samples quickly
- Samples and reagents can be loaded and reloaded continuously without interrupting the assay run
Empower clinicians to improve patient outcomes
- PROTIS® Assessment Software consolidates patient test results into one simple report with algorithm-based interpretation of results to support physicians in clinical decision making
- Lot-to-lot consistency ensures concordance of results, providing physicians with reliable insight into the progression of disease